Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Contemporary evidence supports device-based transcatheter interventions for the
management of patients with structural heart disease. These procedures, which include …

Transcatheter aortic valve replacement (TAVR) is a treatment option for symptomatic
patients with severe aortic stenosis who are candidates for a bioprosthesis across the entire …

Background Tricuspid regurgitation (TR) is a frequent disease with a progressive increase in
mortality as disease severity increases. Transcatheter therapies for treatment of TR may offer …

Objectives No standardized algorithm exists to identify patients at risk of bleeding after
transcatheter aortic valve replacement (TAVR). The aim of this study was to generate and …

Background: Access site vascular and bleeding complications remain problematic for
patients undergoing transcatheter aortic valve replacement (TAVR). Ultrasound-guided …

Transcatheter aortic valve implantation (TAVI) has become the leading technique for aortic
valve replacement in symptomatic patients with severe aortic stenosis with conventional …

Background Major bleeding (MB) events are independent predictors of mortality after
cardiac interventional procedures. The clinical relevance of MB following left atrial …

Background: Bleeding events are among the striking complications following transcatheter
aortic valve replacement (TAVR), and bleeding prediction models are crucially warranted …

Background: Transcatheter aortic valve replacement (TAVR) has developed to the therapy of
choice for patients with symptomatic severe aortic stenosis who are unsuitable for surgical …